Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Hikma Pharmaceuticals ( (GB:HIK) ) is now available.
Hikma Pharmaceuticals has continued executing its previously announced $250 million share repurchase programme, buying back ordinary shares between 27 April and 1 May 2026 on the London Stock Exchange and Cboe Europe. The latest tranche lifts total purchases since the February launch to 5,347,122 shares at a cost of £68.2 million, with the company planning to cancel these shares.
Following settlement and cancellation, Hikma will have 216,539,331 ordinary shares in issue excluding treasury stock, which currently stands at 12,833,233 shares. The reduction in free float and consolidation of voting rights underscores management’s capital-return strategy and may enhance earnings per share and support the stock’s valuation for existing shareholders.
The most recent analyst rating on (GB:HIK) stock is a Buy with a £1800.00 price target. To see the full list of analyst forecasts on Hikma Pharmaceuticals stock, see the GB:HIK Stock Forecast page.
Spark’s Take on HIK Stock
According to Spark, TipRanks’ AI Analyst, HIK is a Neutral.
The score is held back primarily by weakening cash generation and a notably bearish technical trend (oversold and trading below key moving averages). These are partially offset by attractive valuation (low P/E and strong dividend yield) and a constructive earnings-call outlook supported by guidance comfort and a GBP 250m buyback, despite near-term injectable headwinds.
To see Spark’s full report on HIK stock, click here.
More about Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational generic and specialty pharmaceutical company listed in London and on Nasdaq Dubai. The group focuses on producing branded and non-branded generics and injectables, serving hospitals, health systems and retail markets across the U.K., MENA and other international regions.
Average Trading Volume: 1,396,867
Technical Sentiment Signal: Sell
Current Market Cap: £3.03B
For detailed information about HIK stock, go to TipRanks’ Stock Analysis page.